Navigation Links
PEGASYS(R)/COPEGUS(R) Show Benefit in Hard-to-Treat Latino Population with Hepatitis C
Date:5/18/2008

- Largest prospective study in under-treated and under-studied population

(The LATINO Study) provides important insights -

SAN DIEGO, Calif., May 18 /PRNewswire/ -- Roche today announced results from the LATINO study, the largest prospective study to evaluate the response of Latino whites infected with genotype 1 hepatitis C virus (HCV) to combination therapy with pegylated interferon plus ribavirin. The results showed PEGASYS(R) (peginterferon alfa-2a) in combination with COPEGUS(R) (ribavirin) was beneficial in this hard-to-treat population. These data were presented today at the 39th Annual Digestive Disease Week(R) (DDW(R)) in San Diego, CA.

The results showed that 33.5 percent (90/269) of the Latino patients achieved sustained virological response (SVR) when treated with PEGASYS plus COPEGUS. In comparison, 49.3 percent (148/300) of patients in the non-Latino group achieved SVR, a difference of 15.8 percent, highlighting that Latino patients with hepatitis C are more difficult to treat (p < 0.0001). SVR was defined as undetectable HCV RNA 24 weeks after the end of treatment. Additionally, the data provided important information about factors that may predict SVR for Latino patients with hepatitis C.

The study was conducted to help gain a better understanding of hepatitis C treatment in a patient population that has been under-represented in clinical trials and has been known to have lower sustained SVR rates than non-Latino whites.

"We know that Latino patients with hepatitis C face different challenges when treating this disease. It has been reported that Latinos have more aggressive inflammatory activity and fibrosis progression rates than in non-Latino whites," said Maribel Rodriguez-Torres, M.D., of the Fundacion de Investigacion de Diego in Puerto Rico. "Data from studies like LATINO are important for gaining a better understanding about how patients will respond to treatment and for developing culturally-spe
'/>"/>

SOURCE Roche
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Omega 3 Fatty Acids Bound to Phospholipids has Potential Benefit for Attention-Deficit Hyperactivity Disorder (ADHD)
2. Steroids Provide No Survival Benefit for Children With Bacterial Meningitis
3. Annual Conference on Vaccine Research to Highlight Not Only Health Benefits But Also Economic Gains
4. Studies Point to Benefits of Personalized Chemotherapy Dose Management in Colorectal Cancer
5. Poniard Pharmaceuticals Announces Final Picoplatin Data from Phase 2 Small Cell Lung Cancer Trial Demonstrating Survival Benefit
6. FTY720, a novel oral therapy in development for MS, shows sustained benefits for the majority of patients after three years of treatment
7. New Gene Discovery Suggests Which Patients CTIs Brostallicin May Benefit
8. The Yolanda Adams Morning Show and Radio One Gospel Stations Raise More Than $1 Million During National Radiothon Benefiting St. Jude
9. Mayo Clinic Proceedings Contributors Highlight Research Findings About Cardiovascular Benefits Associated With Omega-3 Fatty Acids
10. Novel Small Molecule Therapy Shows Benefit for Anemic Patients Via Hydration of Red Blood Cells
11. IDM Pharma Announces Non-Binding Opinion of the European Committee for Medicinal Products for Human Use (CHMP) that Mifamurtide (L-MTP-PE) Provides a Possible Clinical Benefit in Survival
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... CITY, Kan. , March 4, 2015   ... a pet therapeutics company focused on the licensing, development ... today announced that it will present at the ... 10-12, 2015, at the Loews Miami Beach Hotel in ... Steven St. Peter , M.D., President and Chief ...
(Date:3/4/2015)... March 4, 2015  Results of the recent study, ... Using MarginProbe for Intra-Operative Positive Margin Detection , were ... the 32 nd Annual Miami Breast Cancer Conference ... Moshe Papa , MD, FACS, Professor of Surgery ... University, reports an analysis of MarginProbe,s efficiency and accuracy ...
(Date:3/4/2015)... 2015 Aethlon Medical, Inc. (OTCQB:AEMD), the pioneer in ... cancer, today announced that James A. Joyce , ... overview at the 27th Annual ROTH Conference on March ... Laguna Niguel, California . To learn more about ... A live webcast of the presentation will be ...
Breaking Medicine Technology:Aratana Therapeutics to Present at the Barclays Global Healthcare Conference 2New Study Shows Breast Re-excision Rates Significantly Reduced in 100 Consecutive Cases 2Aethlon Medical to Present at the 27th Annual ROTH Conference 2
... April 22 Genoptix, Inc. (Nasdaq: GXDX ), a specialized ... for the first quarter 2010 after closing of the NASDAQ Global Select Market ... , , ... , Ph.D., and other members of senior management will take place on the ...
... REDWOOD CITY, Calif. , April 22 Codexis, Inc. announced today ... stock, at $13.00 per share. All shares are being sold by ... an additional 900,000 shares at the initial public offering price to cover overallotments, ... the symbol "CDXS." , , , ...
Cached Medicine Technology:Genoptix, Inc. to Announce First Quarter 2010 Financial Results 2Genoptix, Inc. to Announce First Quarter 2010 Financial Results 3Codexis, Inc. Announces Pricing of Initial Public Offering 2
(Date:3/4/2015)... The report covers spices market upstream ... industry development trend and proposals. The report provides ... definitions, applications and industry chain structure. Global market ... with a focus on history, developments, trends and ... the international and Chinese situation is also offered. ...
(Date:3/4/2015)... CITY, GA (PRWEB) March 04, 2015 ... exclusive advanced microfiber technology and their first compression therapy ... huge success of this collection, SIGVARIS USA is proud ... the MIDTOWN MICROFIBER product line. , Constructed from a ... with all-day comfort in mind. These socks and thigh-highs ...
(Date:3/4/2015)... New Port Richey, FL (PRWEB) March 04, 2015 ... Novus Medical Detox cut the ribbon on their new facility ... West Pasco Chamber of Commerce. The new facility will allow ... mission of helping end the prescription drug abuse epidemic through ... the current reality of drug addiction in the United States, ...
(Date:3/4/2015)... Today Visiopharm announces that Patrik Dahlén, previously the ... Visiopharm Board of Directors as Chairman. Mr. ... positioned to become the fastest growing software company, specializing ... , "Over the last several years, Visiopharm ... ONCOtopix™ Dx, a complete quantitative digital pathology solution for ...
(Date:3/4/2015)... A new dieting routine, called the feast and ... life. Studies conducted by the University of ... help extend life by increasing anti-oxidant production. While increased ... many suffering from obesity are already experiencing life shortening ... an alternative to the new Feast and Famine diet, ...
Breaking Medicine News(10 mins):Health News:World Spices Market Overview & Development 2015-2020 Now Available at DeepResearchReports.com 2Health News:World Spices Market Overview & Development 2015-2020 Now Available at DeepResearchReports.com 3Health News:Building on the Success of MIDTOWN MICROFIBER, SIGVARIS Expands Popular Compression Collection with Longer Foot Length Offerings 2Health News:Novus Medical Detox Hosts Ribbon Cutting Ceremony at Pasco County Facility 2Health News:Novus Medical Detox Hosts Ribbon Cutting Ceremony at Pasco County Facility 3Health News:Visiopharm Appoints Patrik Dahlen as Chairman of the Board 2Health News:Visiopharm Appoints Patrik Dahlen as Chairman of the Board 3Health News:Diet Doc Introduces New Alternative to the Feast and Famine Diet 2Health News:Diet Doc Introduces New Alternative to the Feast and Famine Diet 3
... A white paper that examines various state initiatives to expand ... President and Congress in support of state efforts, was distributed ... , The paper, State Experimentation with Reforms to Expand Access ... a part of any state-based reform. It is a summary ...
... only wear an eye patch for three to four hours ... in a study published on bmj.com today. , ... which is often recommended, is almost certainly excessive, they argue. ... between the eyes and the brain, which is often associated ...
... KENSINGTON, Md., Sept. 14 San Francisco will,get an ... tonight as,Psoriasis Cure Now, a nonprofit patient advocacy group, ... to celebrate. Starting at 9:30 pm, two bands,will perform ... this combination,awareness event, fundraiser and party. The suggested donation ...
... Sept. 14 Arrow International,Inc. (Nasdaq: ARRO ) ... voting advisory firm, has advised its clients to vote ... and for the re-election of Arrow,s current Board of ... 20, 2007. Proxy Governance is the fourth proxy ...
... Across the United States, He,s Riding AROUND IT, ... WASHINGTON, Sept. 14 Australian Geoff Thomas,will stop in ... by cycling to all four corners of the country ... kind to raise awareness for lupus, a chronic autoimmune,disease ...
... Sept. 14 As the political turmoil,surrounding stem cells ... - and treatment - that saved his life. John ... AuthorHouse -, http://www.authorhouse.com ), recounts the courageous five-year battle ... of cancer. Settling into a comfortable retirement with ...
Cached Medicine News:Health News:Internal medicine physicians recommend key elements to guide state initiatives 2Health News:Internal medicine physicians recommend key elements to guide state initiatives 3Health News:No need for children with lazy eye to wear patches all day 2Health News:San Francisco Psoriasis Event Tonight Will Celebrate First National Short Sleeve Day 2Health News:Proxy Governance Joins ISS, Glass Lewis and Egan Jones in Recommending Arrow International Shareholders Vote to Approve the $45.50 Per Share Merger With Teleflex 2Health News:Proxy Governance Joins ISS, Glass Lewis and Egan Jones in Recommending Arrow International Shareholders Vote to Approve the $45.50 Per Share Merger With Teleflex 3Health News:Bicyclist to Stop in DC during 9,000 Mile Lap Around the U.S. 2Health News:The Fight for His Life: Author, Family Battle Disease and Challenge Politics in the Face of Survival 2
... Stryker's cystoscope line combines ... intuitive and durable hardware. ... incorporate a robust, ergonomic ... connection found on Stryker ...
... The new EndoEYE Flexible Video Cystoscope from ... surgical technology. By marrying proprietary video chip ... Olympus is now providing a flexible video ... that of a rigid rod lens system. ...
The Olympus continuous flow cystoscope was especially designed for laser treatment of the prostate and for collagen injection....
... is an advanced transurethral microwave thermotherapy ... benign prostate hyperplasia (BPH). TherMatrx is ... thermotherapy treatment in the United States. ... does not require cutting, heavy sedation ...
Medicine Products: